Crossmark Global Holdings’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.5M | Sell |
26,510
-67
| -0.3% | -$29.3K | 0.14% | 157 |
|
|
2026
Q1 | $12.3M | Buy |
26,577
+616
| +2% | +$312K | 0.18% | 135 |
|
|
2025
Q4 | $14.7M | Buy |
25,961
+2,412
| +10% | +$1.28M | 0.21% | 109 |
|
|
2025
Q3 | $10.5M | Buy |
23,549
+1,234
| +6% | +$592K | 0.16% | 154 |
|
|
2025
Q2 | $12.1M | Sell |
22,315
-1,208
| -5% | -$632K | 0.2% | 129 |
|
|
2025
Q1 | $11.7M | Buy |
23,523
+2,905
| +14% | +$1.61M | 0.21% | 122 |
|
|
2024
Q4 | $10.8M | Sell |
20,618
-57
| -0.3% | -$29.7K | 0.2% | 130 |
|
|
2024
Q3 | $10.2M | Sell |
20,675
-973
| -4% | -$453K | 0.18% | 138 |
|
|
2024
Q2 | $9.63M | Buy |
21,648
+261
| +1% | +$104K | 0.18% | 136 |
|
|
2024
Q1 | $8.54M | Sell |
21,387
-41
| -0.2% | -$15.5K | 0.16% | 153 |
|
|
2023
Q4 | $7.23M | Sell |
21,428
-379
| -2% | -$113K | 0.15% | 164 |
|
|
2023
Q3 | $6.49M | Sell |
21,807
-653
| -3% | -$204K | 0.15% | 173 |
|
|
2023
Q2 | $7.33M | Sell |
22,460
-605
| -3% | -$183K | 0.16% | 168 |
|
|
2023
Q1 | $5.89M | Sell |
23,065
-699
| -3% | -$172K | 0.14% | 185 |
|
|
2022
Q4 | $6.31M | Buy |
23,764
+1,105
| +5% | +$269K | 0.16% | 165 |
|
|
2022
Q3 | $4.25M | Sell |
22,659
-204
| -0.9% | -$43.8K | 0.12% | 205 |
|
|
2022
Q2 | $4.59M | Sell |
22,863
-215
| -0.9% | -$50.4K | 0.12% | 203 |
|
|
2022
Q1 | $6.96M | Sell |
23,078
-7,867
| -25% | -$2.3M | 0.16% | 165 |
|
|
2021
Q4 | $11.1M | Sell |
30,945
-74,949
| -71% | -$25.8M | 0.24% | 111 |
|
|
2021
Q3 | $11.7M | Buy |
105,894
+70,053
| +195% | +$23.5M | 0.27% | 98 |
|
|
2021
Q2 | $11M | Sell |
35,841
-1,293
| -3% | -$363K | 0.26% | 100 |
|
|
2021
Q1 | $9.15M | Sell |
37,134
-3
| -0% | -$755 | 0.23% | 112 |
|
|
2020
Q4 | $10.1M | Sell |
37,137
-2,124
| -5% | -$527K | 0.26% | 94 |
|
|
2020
Q3 | $9.29M | Sell |
39,261
-708
| -2% | -$159K | 0.26% | 97 |
|
|
2020
Q2 | $7.59M | Buy |
39,969
+2,598
| +7% | +$466K | 0.22% | 110 |
|
|
2020
Q1 | $6.17M | Buy |
37,371
+921
| +3% | +$169K | 0.22% | 116 |
|
|
2019
Q4 | $7.18M | Buy |
36,450
+195
| +0.5% | +$36.5K | 0.2% | 126 |
|
|
2019
Q3 | $6.53M | Sell |
36,255
-1,395
| -4% | -$241K | 0.19% | 134 |
|
|
2019
Q2 | $6.58M | Sell |
37,650
-1,968
| -5% | -$337K | 0.18% | 131 |
|
|
2019
Q1 | $7.54M | Sell |
39,618
-1,458
| -4% | -$259K | 0.21% | 125 |
|
|
2018
Q4 | $6.56M | Sell |
41,076
-2,616
| -6% | -$443K | 0.2% | 133 |
|
|
2018
Q3 | $8.36M | Buy |
43,692
+8,931
| +26% | +$1.59M | 0.21% | 119 |
|
|
2018
Q2 | $5.54M | Sell |
34,761
-3,132
| -8% | -$478K | 0.15% | 168 |
|
|
2018
Q1 | $5.21M | Sell |
37,893
-2,853
| -7% | -$398K | 0.13% | 188 |
|
|
2017
Q4 | $4.96M | Buy |
40,746
+1,227
| +3% | +$154K | 0.12% | 211 |
|
|
2017
Q3 | $4.59M | Buy |
+39,519
| New | +$4.31M | 0.12% | 210 |
|
|
2016
Q3 | $4.59M | Buy |
+39,519
| New | +$3.03M | 0.12% | 210 |
|
Other funds holding ISRG
Crossmark Global Holdings's ISRG Position: Q2 2026 in Review
Crossmark Global Holdings reduced its Intuitive Surgical (ISRG) stake by 0.25% in Q2 2026, selling an estimated $29.3K and leaving 26,510 shares worth $10.5M. The position accounts for 0.14% of the portfolio, ranked #157.
Crossmark Global Holdings first reported a position in ISRG in Q3 2016 and has held it in 37 quarters since. The position peaked at $14.7M in Q4 2025. 2,244 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- Crossmark Global Holdings held 26,510 shares of Intuitive Surgical worth $10.5M as of Q2 2026.
- Crossmark Global Holdings sold 67 Intuitive Surgical shares in Q2 2026, an estimated $29.3K.
- Intuitive Surgical made up 0.14% of Crossmark Global Holdings's portfolio in Q2 2026, its #157 holding.
- Crossmark Global Holdings first reported a position in Intuitive Surgical in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's Intuitive Surgical position peaked at $14.7M in Q4 2025.
- 2,244 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.